Callan et al., 2009 - Google Patents
Canine platelet transfusionsCallan et al., 2009
View PDF- Document ID
- 4583191764481383718
- Author
- Callan M
- Appleman E
- Sachais B
- Publication year
- Publication venue
- Journal of Veterinary Emergency and Critical Care
External Links
Snippet
Objective–To review potential platelet storage options, guidelines for administration of platelets, and adverse events associated with platelet transfusions. Data Sources–Data sources included original research publications and scientific reviews. Human Data …
- 210000001772 Blood Platelets 0 title abstract description 534
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0215—Disinfecting agents, e.g. antimicrobials for preserving living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0413—Blood
- A61M2202/0429—Red blood cells; Erythrocytes
- A61M2202/0437—Blood stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zimrin et al. | Current issues relating to the transfusion of stored red blood cells | |
Callan et al. | Canine platelet transfusions | |
Hess | An update on solutions for red cell storage | |
McMichael et al. | Effect of leukoreduction on transfusion‐induced inflammation in dogs | |
Adams et al. | Biochemical storage lesions occurring in nonirradiated and irradiated red blood cells: a brief review | |
Högman et al. | Red blood cells intended for transfusion: quality criteria revisited | |
Arya et al. | Blood component therapy: which, when and how much | |
Cid et al. | In vitro evaluation of the hemostatic effectiveness of cryopreserved platelets | |
Hegde et al. | Towards increasing shelf life and haemostatic potency of stored platelet concentrates | |
Sparrow et al. | In vitro measures of membrane changes reveal differences between red blood cells stored in saline‐adenine‐glucose‐mannitol and AS‐1 additive solutions: a paired study | |
Hux et al. | Platelet transfusions: treatment options for hemorrhage secondary to thrombocytopenia | |
Wilsher et al. | The effect of storing whole blood at 22° C for up to 24 hours with and without rapid cooling on the quality of red cell concentrates and fresh‐frozen plasma | |
Lacerda et al. | Effects of four additive solutions on canine leukoreduced red cell concentrate quality during storage | |
Holovati et al. | The effects of cryopreservation on red blood cell microvesiculation, phosphatidylserine externalization, and CD47 expression | |
Mudge et al. | Comparison of 4 blood storage methods in a protocol for equine pre‐operative autologous donation | |
Snyder et al. | In vitro and in vivo evaluation of a whole blood platelet‐sparing leukoreduction filtration system | |
Kogler et al. | There and back again: the once and current developments in donor-derived platelet products for hemostatic therapy | |
Sputtek | Cryopreservation of red blood cells and platelets | |
Lozano et al. | Platelet cryopreservation using a reduced dimethyl sulfoxide concentration and second-messenger effectors as cryopreserving solution | |
Gelderman et al. | Rejuvenation improves roller pump–induced physical stress resistance of fresh and stored red blood cells | |
Walker | Component therapy | |
Holovati et al. | Blood preservation workshop: New and emerging trends in research and clinical practice | |
Vassallo Jr | Preparation, preservation, and storage of platelet concentrates | |
Silberman | Platelets: preparations, transfusion, modifications, and substitutes | |
Thomas et al. | Blood components produced from whole blood using the Atreus processing system |